SLGL
Price
$11.00
Change
-$0.11 (-0.99%)
Updated
Jul 25 closing price
Capitalization
30.64M
11 days until earnings call
TRAW
Price
$1.58
Change
-$0.05 (-3.07%)
Updated
Jul 25 closing price
Capitalization
8.79M
Interact to see
Advertisement

SLGL vs TRAW

Header iconSLGL vs TRAW Comparison
Open Charts SLGL vs TRAWBanner chart's image
Sol-Gel Technologies
Price$11.00
Change-$0.11 (-0.99%)
Volume$11.25K
Capitalization30.64M
Traws Pharma
Price$1.58
Change-$0.05 (-3.07%)
Volume$91.37K
Capitalization8.79M
SLGL vs TRAW Comparison Chart in %
Loading...
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SLGL vs. TRAW commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SLGL is a Buy and TRAW is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (SLGL: $11.00 vs. TRAW: $1.58)
Brand notoriety: SLGL and TRAW are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SLGL: 62% vs. TRAW: 6%
Market capitalization -- SLGL: $30.64M vs. TRAW: $8.79M
SLGL [@Biotechnology] is valued at $30.64M. TRAW’s [@Biotechnology] market capitalization is $8.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SLGL’s FA Score shows that 0 FA rating(s) are green whileTRAW’s FA Score has 1 green FA rating(s).

  • SLGL’s FA Score: 0 green, 5 red.
  • TRAW’s FA Score: 1 green, 4 red.
According to our system of comparison, both SLGL and TRAW are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SLGL’s TA Score shows that 6 TA indicator(s) are bullish while TRAW’s TA Score has 5 bullish TA indicator(s).

  • SLGL’s TA Score: 6 bullish, 4 bearish.
  • TRAW’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, both SLGL and TRAW are a good buy in the short-term.

Price Growth

SLGL (@Biotechnology) experienced а +35.30% price change this week, while TRAW (@Biotechnology) price change was -1.25% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.62%. For the same industry, the average monthly price growth was +17.39%, and the average quarterly price growth was +28.36%.

Reported Earning Dates

SLGL is expected to report earnings on Nov 06, 2025.

TRAW is expected to report earnings on May 15, 2025.

Industries' Descriptions

@Biotechnology (+7.62% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SLGL($30.6M) has a higher market cap than TRAW($8.79M). SLGL YTD gains are higher at: 18.267 vs. TRAW (-82.207). SLGL has higher annual earnings (EBITDA): -9.66M vs. TRAW (-24.89M). SLGL has more cash in the bank: 16.9M vs. TRAW (15.9M). SLGL has higher revenues than TRAW: SLGL (12.1M) vs TRAW (227K).
SLGLTRAWSLGL / TRAW
Capitalization30.6M8.79M348%
EBITDA-9.66M-24.89M39%
Gain YTD18.267-82.207-22%
P/E RatioN/AN/A-
Revenue12.1M227K5,330%
Total Cash16.9M15.9M106%
Total Debt1.18MN/A-
FUNDAMENTALS RATINGS
SLGL vs TRAW: Fundamental Ratings
SLGL
TRAW
OUTLOOK RATING
1..100
4412
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
27
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
3665
P/E GROWTH RATING
1..100
97100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TRAW's Valuation (27) in the Biotechnology industry is in the same range as SLGL (52) in the Pharmaceuticals Major industry. This means that TRAW’s stock grew similarly to SLGL’s over the last 12 months.

TRAW's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as SLGL (100) in the Pharmaceuticals Major industry. This means that TRAW’s stock grew similarly to SLGL’s over the last 12 months.

SLGL's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as TRAW (100) in the Biotechnology industry. This means that SLGL’s stock grew similarly to TRAW’s over the last 12 months.

SLGL's Price Growth Rating (36) in the Pharmaceuticals Major industry is in the same range as TRAW (65) in the Biotechnology industry. This means that SLGL’s stock grew similarly to TRAW’s over the last 12 months.

SLGL's P/E Growth Rating (97) in the Pharmaceuticals Major industry is in the same range as TRAW (100) in the Biotechnology industry. This means that SLGL’s stock grew similarly to TRAW’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SLGLTRAW
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 10 days ago
75%
Declines
ODDS (%)
Bearish Trend 19 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
SLGL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRAW
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPMT2.660.08
+3.10%
Granite Point Mortgage Trust
GATX153.471.19
+0.78%
GATX Corp
OXY44.710.08
+0.18%
Occidental Petroleum Corp
BLX41.74-0.44
-1.04%
Banco Latinoamericano de Comercio Exterior SA
HTCO0.23-0.01
-2.30%
High-Trend International Group

SLGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, SLGL has been loosely correlated with TRAW. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SLGL jumps, then TRAW could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLGL
1D Price
Change %
SLGL100%
-0.99%
TRAW - SLGL
47%
Loosely correlated
-6.51%
RAPT - SLGL
40%
Loosely correlated
+5.22%
GTBP - SLGL
32%
Poorly correlated
-3.74%
RPRX - SLGL
29%
Poorly correlated
+0.22%
AVXL - SLGL
28%
Poorly correlated
-4.79%
More